Literature DB >> 15277278

A practical and evidence-based approach to cardiovascular disease risk reduction.

Ty J Gluckman1, Bryan Baranowski, M Dominique Ashen, Charles A Henrikson, Marc McAllister, Joel B Braunstein, Roger S Blumenthal.   

Abstract

Implementation of the numerous lifestyle and medical management options for secondary prevention of cardiovascular disease remains a daunting goal for primary care physicians and cardiologists alike. Despite the existence of expert consensus guidelines on cardiovascular prevention by the American College of Cardiology and the American Heart Association, therapies known to improve patient care and decrease morbidity and mortality remain underutilized. This review attempts to simplify cardiovascular risk reduction by summarizing key clinical trials in an "ABC" format. We believe that if health care providers and patients use such a format, important lifestyle and pharmacologic options will more likely be addressed.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15277278     DOI: 10.1001/archinte.164.14.1490

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  8 in total

1.  Facts and ideas from anywhere.

Authors:  William Clifford Roberts
Journal:  Proc (Bayl Univ Med Cent)       Date:  2004-10

2.  Highly active antiretroviral therapy.

Authors:  Filip Moerman; Alfons Van Gompel; Jan Nimmegeers; Johan Moerman
Journal:  BMJ       Date:  2005-06-11

Review 3.  Primary prevention for patients with intermediate Framingham risk scores.

Authors:  Jason B Thompson; Juan J Rivera; Roger S Blumenthal; Peter Danyi
Journal:  Curr Cardiol Rep       Date:  2006-07       Impact factor: 2.931

Review 4.  The Polymeal: a more natural, safer, and probably tastier (than the Polypill) strategy to reduce cardiovascular disease by more than 75%.

Authors:  Oscar H Franco; Luc Bonneux; Chris de Laet; Anna Peeters; Ewout W Steyerberg; Johan P Mackenbach
Journal:  BMJ       Date:  2004-12-18

5.  ACCF/AHA/ACP 2009 competence and training statement: a curriculum on prevention of cardiovascular disease: a report of the American College of Cardiology Foundation/American Heart Association/American College of Physicians Task Force on Competence and Training (Writing Committee to Develop a Competence and Training Statement on Prevention of Cardiovascular Disease): developed in collaboration with the American Academy of Neurology; American Association of Cardiovascular and Pulmonary Rehabilitation; American College of Preventive Medicine; American College of Sports Medicine; American Diabetes Association; American Society of Hypertension; Association of Black Cardiologists; Centers for Disease Control and Prevention; National Heart, Lung, and Blood Institute; National Lipid Association; and Preventive Cardiovascular Nurses Association.

Authors:  C Noel Bairey Merz; Mark J Alberts; Gary J Balady; Christie M Ballantyne; Kathy Berra; Henry R Black; Roger S Blumenthal; Michael H Davidson; Sara B Fazio; Keith C Ferdinand; Lawrence J Fine; Vivian Fonseca; Barry A Franklin; Patrick E McBride; George A Mensah; Geno J Merli; Patrick T O'Gara; Paul D Thompson; James A Underberg
Journal:  J Am Coll Cardiol       Date:  2009-09-29       Impact factor: 24.094

6.  Evidence of lung function for stratification of cardiovascular disease risk.

Authors:  Hwa Mu Lee; Steven T Truong; Nathan D Wong
Journal:  Korean Circ J       Date:  2011-04-30       Impact factor: 3.243

7.  Salvia Miltiorrhiza Root Water-Extract (Danshen) Has No Beneficial Effect on Cardiovascular Risk Factors. A Randomized Double-Blind Cross-Over Trial.

Authors:  Pleun C M van Poppel; Pauline Breedveld; Evertine J Abbink; Hennie Roelofs; Waander van Heerde; Paul Smits; Wenzhi Lin; Aaitje H Tan; Frans G Russel; Rogier Donders; Cees J Tack; Gerard A Rongen
Journal:  PLoS One       Date:  2015-07-20       Impact factor: 3.240

8.  Cardiovascular disease risk reduction in rural China: a clustered randomized controlled trial in Zhejiang.

Authors:  Xiaolin Wei; Guanyang Zou; Weiwei Gong; Jia Yin; Yunxian Yu; John Walley; Zhitong Zhang; Rebecca King; Kun Chen; Marc Ka Chun Chong; Benny Chung Ying Zee; Su Liu; Jinling Tang; Sian Griffiths; Min Yu
Journal:  Trials       Date:  2013-10-25       Impact factor: 2.279

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.